systemic diseases: what is this?
TRANSCRIPT
11/8/2021
1
Systemic Diseases and Their
Impact on the Retina
Michael W. Stewart, MD
Professor and Chairman
Department of Ophthalmology
Mayo Clinic Florida
Allergan: Research Support
Alkahest: Consultant
Bayer: Consultant
Biogen: Consultant
Regeneron: Research Support
Santen: Research Support
DisclosureCase
• 42 year old ♀ sent by primary physician for
decreased vision OS for 2 weeks. Also c/o strange
flashing lights.
• No significant medical history.
• Had complete physical 1 month ago.
• 25 pack year history of smoking.
• Review of systems:
– Mild non-productive cough for 2 months.
– Lower back pain for 6 weeks.
1 2
3 4
5 6
11/8/2021
2
7 8
9 10
11 12
11/8/2021
3
Overview
• Systemic diseases may frequently involve the eyes and orbit
cause visual symptoms through secondary effects.
• Accurate diagnoses can frequently be made with a careful
ocular and systemic history. In medicine:
– 80% diagnoses made by history
– 10% by examination
– 10% by ancillary testing.
• Each component of the ocular examination – including
visual field and pupillary testing – can contribute critical
information to making the diagnosis.
Ocular Metastases
• Outnumber primary ocular malignancies 9:1
• Up to 18% of autopsied eyes of cancer patients
have choroidal metastases.
• Most common ophthalmic sites are choroid and
orbit.
• Typical complaints: blurred vision, visual field
defect, photopsias, pain, proptosis, diplopia.
• Most common primaries: breast, lung, colon.
Choroidal Metastases
• Creamy color
• 25% multiple
• Retinal Detachment
• Primary tumor is
usually known
• 64 year old lady with pain OD
• Hx of lung and cervical Ca
• Lung nodule followed 1 yr.
• 60 y.o. ♀ with treated non-metastatic breast cancer
now in remission.
• Found to have this lesion on routine eye exam.
• Given diagnosis of metastatic breast cancer!
• Recommended to have radiation and chemotherapy.
6 weeks later
13 14
15 16
17 18
11/8/2021
4
Systemic Diseases & Eye Findings
• Neoplasia
– Metastatic cancer
– Cancer-associated
retinopathy
• Vascular Diseases
– Hypertension and
retinopathy
– Diabetic retinopathy
• Infectious Diseases
– HIV/AIDS
• Inflammatory Diseases
– Rheumatoid scleritis
• Medications
– Plaquenil
Case
• 58 y.o. ♀ c/o decreased vision OU for 2
years
– Seen by a retina specialist 2 years ago but no
diagnosis.
– Developed a retinal detachment OS 1 year ago
fixed with vitrectomy – no improvement in
vision
– Now with 20/400 OU
– Medical hx:
• Breast CA in remission last evaluated 6 months ago
• No hx of abdominal surgery
Extramacular thinning with outer retinal loss
Summary
• Poor vision, thin retinas, hx of cancer
• Testing
– Normal vitamin concentrations, heavy metals,
FTA
– Anti-retinal antibody testing: antibodies
detected to 5 of 8 antigens tested
• Diagnosis of Autoimmune retinopathy
(idiopathic vs. cancer-associated)
Work-up
• Refer to Oncology to look for active breast
cancer
– Pet MRI showed
• Hilar and cervical lymph nodes
• Vertebral
– Positive biopsy of lymph node for breast Ca.
19 20
21 22
23 24
11/8/2021
5
Systemic Diseases & Eye Findings
• Neoplasia
– Metastatic cancer
– Cancer-associated
retinopathy
• Vascular Diseases
– Hypertension and
retinopathy
– Diabetic retinopathy
• Infectious Diseases
– HIV/AIDS
• Inflammatory Diseases
– Rheumatoid scleritis
• Medications
– Plaquenil
CASE
• 51 y.o. slim white female c/o blurred VA.
• Had LASIK 6 months ago.
• Seen 1.5 months ago with dry eyes.
• Recently stopped her anti-hypertensive
medication due to worsening dry eyes.
• Visual acuity
– OD: 20/25-
– OS: 20/20-
Both retinal and choroidal vascular
involvement Blood Pressure
225/150
Treatment: immediate transfer to ER.
Patients usually admitted for BP
control. Often have co-existing
kidney damage.
25 26
27 28
29 30
11/8/2021
6
Case
• 64 y.o. healthy ♂ c/o 4 weeks of new onset
headaches, mild GI distress, fatigue & malaise.
• Completely healthy except for history of BPH
(benign prostatic hypertrophy) with urinary
frequency that had been worsening recently.
• Noted sudden onset of monocular scotoma OS.
31 32
33 34
35 36
11/8/2021
7
What test should should be
done next?
BP: 180/110
What is the cause of this?
What other testing should be done?
Workup of Grade 3 Hypertensive
Retinopathy
• Urgent medical consult– Some would argue for evaluation in the Emergency
Department.
• Medical Exam– Otherwise unremarkable exam.
– Electrocardiogram: Normal
– Labs:
• Hb/HCT – 11.8/33.6
• Creatinine – 3.11 (normal <1.35)
– Residual bladder volume: 1000 ml (normal: 50-100)
Work-up continued…
• Renal Ultrasound shows obstructive
uropathy with dilated ureters and
hydronephrosis
Treatment
• Hospitalization– Urinary catheter
– Control of blood pressure
– Elective TURP trans-urethral resection of the
prostate
• 4 weeks later– BP: 125/77
– Hb/Hct: 13.6/39.1
– Creatinine: 1.72
– Post-void residual: 23 ml
9/20
10/12
Hypertensive Retinopathy
• Scheie Classification
• Normal
• Grade 1: mild arteriolar narrowing
• Grade 2: localized irregularity and
constriction
• Grade 3: CWSs and hemorrhages
• Grade 4: papilledema
37 38
39 40
41 42
11/8/2021
8
Systemic Diseases & Eye Findings
• Neoplasia
– Metastatic cancer
– Cancer-associated
retinopathy
• Vascular Diseases
– Hypertension and
retinopathy
– Diabetic retinopathy
• Infectious Diseases
– HIV/AIDS
• Inflammatory Diseases
– Rheumatoid scleritis
• Medications
– Plaquenil
2nd opinion for DME s/p IVTriamcinolone x 1
What treatment would you recommend for the right eye?
1. Macular laser
2. Bevacizumab
3. Ranibizumab
4. Aflibercept
5. Ozurdex
6. Vitrectomy
OD: 20/50 OS: 20/150
Aflibercept injected monthly
20/50
20/40
20/40
20/30
Baseline
2 months
5 months
19 monthss/p Aflibercept x 14
Aflibercept
monthly x 2
Aflibercept
monthly x 3
Aflibercept
q2month x 8
What treatment would you recommend for the left eye?
1. Macular laser
2. Bevacizumab
3. Ranibizumab
4. Aflibercept
5. Ozurdex
6. Vitrectomy
20/15020/50
Patient underwent vitrectomy with
membrane stripping OS
Baseline
Vitrectomy/MS
1 month
5 months
36 months
CE/IOL
No Injections
20/150
20/25
20/70
20/100
OD OS
ODOS1 month later
43 44
45 46
47 48
11/8/2021
9
Diabetic Retinopathy
• Background diabetic retinopathy (BDR)
– microaneurysms, hemorrhages, cotton wool
spots, hard exudates
• Proliferative diabetic retinopathy (PDR)
– neovascularization of retina or disc
• Pre-proliferative diabetic retinopathy
(PPDR)
– IRMA, venous beading
Diabetes Mellitus
• 9.5% of U.S. population is afflicted.
• 90% are type 2 (generally adult).
• Diet and exercise are crucial to control.
• Patients are treated with insulin and/or
oral hypoglycemic drugs.
• Number 7 cause of death.
Fluorescein Angiogram Systemic Diseases & Eye Findings
• Neoplasia
– Metastatic cancer
– Cancer-associated
retinopathy
• Vascular Diseases
– Hypertension and
retinopathy
– Diabetic retinopathy
• Infectious Diseases
– HIV/AIDS
• Inflammatory Diseases
– Rheumatoid scleritis
• Medications
– Plaquenil
49 50
51 52
53 54
11/8/2021
10
Holland et al. AJO 1982
7 patients with CMV retinitis, retinal
periphlebitis and Kaposi’s sarcoma
Kaposi’s SarcomaPost Infectious scarring
Active retinitis
Unaffected retina
CMV Retinitis
AIDS retinopathy
HIV Retinopathy
Herpes Zoster
• Progressive Outer Retinal Necrosis (PORN)
• Rx. with acyclovir + foscavir or intravit ganciclovir
55 56
57 58
59 60
11/8/2021
11
Ocular Toxoplasmosis
• frequently associated with CNS disease
• may be multifocal
Pneumocystis choroidal infiltrates
AIDS Eye Disease
• Epidemic through early 1990s (CMV retinitis in 20-40% of patients).
• Incidence of retinitis increases with low CD4+ counts. CMV generally occurs with CD4+ < 50.
• Other problems range from keratitis, orbital tumors, optic neuropathies, intracranial tumors to infections.
• Incidence of CMV retinitis decreased up to 80% following introduction of protease inhibitors in 1995. This treatment regimen was known as HAART (Highly Active Anti-Retroviral Therapy).
Systemic Diseases & Eye Findings
• Neoplasia
– Metastatic cancer
– Cancer-associated
retinopathy
• Vascular Diseases
– Hypertension and
retinopathy
– Diabetic retinopathy
• Infectious Diseases
– HIV/AIDS
• Inflammatory Diseases
– Rheumatoid scleritis
• Medications
– Plaquenil
Case
• 40 y.o. African American female
developed severe headaches 2 wk.
previously.
• Mostly left sided: orbit to occiput
• Transient visual changes OS with
headache.
• Diagnosed with new-onset migraine:
given trial of Imitrex.
61 62
63 64
65 66
11/8/2021
12
Case … cont’d
• Now 2 day history of constant blurred VA
OS.
• Ophthalmic Hx: “retinal detachment”
OD 15 yrs. ago.
• Current exam
– VA: OD - 20/20; OS - 20/400
– Normal anterior segments
– No APD
Case … cont’d
• B-scan OS:
– 1. Subretinal fluid inferiorly.
– 2. Choroidal and scleral thickening.
Case … cont’d
• DX: Posterior scleritis
• Evaluation:
– ESR, ANA, ANCA negative
– Rheumatoid factor positive
• Treatment: Prednisone 60 mg QD
• Rheumatoid work-up to evaluate for arthritis.
67 68
69 70
71 72
11/8/2021
13
Four weeks later
VA = 20/20
Systemic Diseases & Eye Findings
• Neoplasia
– Metastatic cancer
– Cancer-associated
retinopathy
• Vascular Diseases
– Hypertension and
retinopathy
– Diabetic retinopathy
• Infectious Diseases
– HIV/AIDS
• Inflammatory Diseases
– Rheumatoid scleritis
• Medications
– Plaquenil
Case
• 62 y.o ♀ with 20+ year history of
rheumatoid arthritis and Sjogren’s.
• Takes Plaquenil 600 mg (3 pills) per day
for 20 year.
• Referred for possible plaquenil toxicity
based on appearance of OCT.
• VA is 20/25 OU
• Takes serum drops for severe dry eyes.
73 74
75 76
77 78
11/8/2021
14
Plaquenil toxicity
• Risk of toxicity
– Dependent on dose and length of treatment
– 1% at 5 years
– 2% at 10 years
– 20% at 20 years1% of patients receiving
hydroxychloroquine
• Recommended dose is <5 mg/kg ideal
body weight.
Plaquenil toxicity
• Annual screening recommended at 5
years
– Recommended HVF and SD-OCT
– Additional tests include FAF and mERG
• Screening should detect damage before it
becomes ophthalmoscopically visible.
• No treatment available; damage can occur
for 4 months after d/c of drug.
Thank you
79 80
81